Determine Announces 3rd Quarter Fiscal Year 2017 Financial

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
112
Determine Announces 3rd Quarter Fiscal Year 2017 Financial Results, Exceeding Revenue and Earnings Expectations

CARMEL, IN--(Marketwired - Feb 9, 2017) - Determine , Inc. ( NASDAQ : DTRM ), a leading global provider of SaaS enterprise Source to Pay and Enterprise Contract Lifecycle Management solutions, including cloud-based strategic sourcing, supplier management, contract management and procure-to-pay solutions, announced financial results for its third fiscal quarter ended December 31, 2016.

Q3 FY2017 GAAP Financial Highlights:

  • GAAP revenue was $6.9 million in Q3 FY2017, compared to $6.6 million in Q2 FY2017, representing a 4.1% increase quarter-over-quarter, and compared to $7.1 million in Q3 FY2016 GAAP revenue, representing a 3.5% decrease year-over-year.
  • GAAP gross profit percentage increased to 48.8% in Q3 FY2017, compared to 47.7% in Q2 FY2017, representing a quarter-over-quarter increase of 1.1 percentage points, and compared to 51.9% in Q3 FY2016, representing a 3.1 percentage points decrease year-over-year.
  • Deferred revenues increased 11.1% to $10.0 million in Q3 FY2017 from $9.0 million in Q3 FY2016.
  • GAAP net loss was $2.2 million or ($0.18) per share in Q3 FY2017, compared to $3.2 million or ($0.28) per share in Q2 FY2017, representing a $0.10 improvement per share quarter-over-quarter; in Q3 FY2016 the GAAP net loss was $2.8 million or ($0.25) per share.

                                                                          (in thousands, except per share amounts)

 
GAAP Financial Measures   Q3     Q2     Q3     Change     Change     Nine Months  
  FY 2017     FY 2017     FY 2016     Q/Q     Y/Y     FY 2017'     FY 2016'     Change Y/Y  
Revenue - total   $ 6,852     $ 6,584     $ 7,100       4.1 %     (3.5 %)   $ 19,928     $ 20,080       (0.8 %)
Revenue - recurring   $ 5,054     $ 5,145     $ 5,354       (1.8 %)     (5.6 %)   $ 15,267     $ 15,862       (3.8 %)
Revenue - non-recurring   $ 1,798     $ 1,439     $ 1,746       24.9 %     3.0 %   $ 4,661     $ 4,218       10.5 %
Gross profit - total   $ 3,341     $ 3,138     $ 3,682       6.5 %     (9.3 %)   $ 9,865     $ 10,494       (6.0 %)
Gross profit - recurring   $ 3,277     $ 3,442     $ 3,538       (4.8 %)     (7.4 %)   $ 10,182     $ 10,859       (6.2 %)
Gross profit/ (loss) - non-recurring   $ 64     $ (304 )   $ 144       121.0 %     (55.6 %)   $ (317 )   $ (365 )     13.2 %
Gross margin - total     48.8 %     47.7 %     51.9 %     1.1 pts       (3.1 pts )     49.5 %     52.3 %     (2.8 pts )
Gross margin - recurring     64.8 %     66.9 %     66.1 %     (2.1 pts )     (1.3 pts )     66.7 %     68.5 %     (1.8 pts )
Gross margin - non recurring     3.5 %     (21.1 %)     8.2 %     24.6 pts       (4.7 pts )     (6.8 %)     (8.7 %)     1.9 pts  
Net loss   $ (2,193 )   $ (3,207 )   $ (2,845 )     31.6 %     22.9 %   $ (7,743 )   $ (10,212 )     24.2 %
EPS   $ (0.18 )   $ (0.28 )   $ (0.25 )   $ 0.10     $ 0.07     $ (0.67 )   $ (0.90 )   $ 0.23  
                                                                 

Q3 FY2017 Non-GAAP Financial Highlights:

  • Non-GAAP revenue was $6.9 million in Q3 FY2017, compared to $6.6 million in Q2 FY2017, representing a 4.1% quarter-over-quarter increase, and compared to $7.2 million in Q3 FY2016, representing a 4.7% decrease year-over-year.
  • Non-GAAP gross profit percentage was 54.4% in Q3 FY2017, compared to 52.5% in Q2 FY2017, representing a 1.9 percentage point increase, and compared to 57.5% in Q3 FY2016, representing a 3.1 percentage point decrease.
  • Non-GAAP net loss was $1.0 million or ($0.08) per share in Q3 FY2017, compared to $2.0 million or ($0.17) per share in Q2 FY2017, representing an improvement of $0.09 per share quarter-over-quarter, compared to $1.5 million or ($0.13) per share in Q3 FY2016, representing a $0.05 improvement per share year-over-year.
  • Billings decreased 3.3% to $7.5 million in Q3 FY2017 from $7.8 million in Q3 FY2016. Billings, a non-GAAP measure, are defined as revenue plus the change in deferred revenues.
  • Non-GAAP EBITDA was ($0.2) million in Q3 FY2017, and compared to ($1.4) million in Q3 FY2016, representing an improvement of $1.2 million year-over-year.

(in thousands, except per share amounts)                                                                          

 
Non-GAAP Financial Measures   Q3     Q2     Q3     Change     Change     Nine Months  
  FY 2017     FY 2017     FY 2016     Q/Q     Y/Y     FY 2017'     FY 2016'     Change Y/Y  
Revenue - total   $ 6,852     $ 6,584     $ 7,187       4.1 %     (4.7 %)   $ 19,936     $ 20,308       (1.8 %)
Revenue - recurring   $ 5,054     $ 5,145     $ 5,400       (1.8 %)     (6.4 %)   $ 15,275     $ 16,021       (4.7 %)
Revenue - non-recurring   $ 1,798     $ 1,439     $ 1,787       24.9 %     0.6 %   $ 4,661     $ 4,287       8.7 %
Gross profit - total   $ 3,726     $ 3,460     $ 4,135       7.7 %     (9.9 %)   $ 10,896     $ 11,677       (6.7 %)
Gross profit - recurring   $ 3,591     $ 3,710     $ 3,859       (3.2 %)     (7.0 %)   $ 11,037     $ 11,736       (6.0 %)
Gross profit/( loss) - non-recurring   $ 135     $ (250 )   $ 276       154.0 %     (51.1 %)   $ (141 )   $ (59 )     (139.0 %)
Gross margin - total     54.4 %     52.5 %     57.5 %     1.9 pts       (3.1 pts )     54.7 %     57.5 %     (2.8 pts )
Gross margin - recurring     71.0 %     72.1 %     71.5 %     (1.1 pts )     (0.5 pts )     72.3 %     73.3 %     (1.0 pts )
Gross margin - non recurring     7.5 %     (17.4 %)     15.5 %     24.9 pts       (8.0 pts )     (3.0 %)     (1.4 %)     (1.6 pts )
Net loss   $ (1,010 )   $ (1,959 )   $ (1,503 )     48.4 %     32.8 %   $ (4,253 )   $ (4,585 )     7.2 %
EPS   $ (0.08 )   $ (0.17 )   $ (0.13 )   $ 0.09     $ 0.05     $ (0.37 )   $ (0.45 )   $ 0.08  
Billings   $ 7,545     $ 5,770     $ 7,800       30.8 %     (3.3 %)   $ 19,595     $ 20,667       (5.2 %)
                                                                 

"This quarter we are very pleased by our return to the million dollar range for new Annualized Bookings, with quarter-over-quarter new sales growing at a rate in excess of 30%. Driving the sales performance was our disruptive, new Determine Cloud Platform offering, with over 90% of our new customers opting for the platform for their Source-to-Pay or Enterprise Contract Lifecycle Management needs," said Patrick Stakenas, President and CEO of Determine. "Over the coming months, we look forward to continuing to focus on several key executional tasks including advancing the Determine Cloud Platform's capabilities -- to provide our customers with 'Platformance', continuing to optimize organizational efficiencies, and building upon our robust lead pipeline to deliver incremental and accelerated sales in the coming quarters."

Q3 FY2017 Business Highlights:

  • Annualized Bookings: The sales team delivered approximately $983,000 in Annualized Bookings for the quarter, with more than 90% of new customers selecting the new Determine Cloud Platform for their Source-to-Pay or Contract Lifecycle Management needs.
  • Determine Cloud Platform Empowers Companies in Source-to-Pay and Enterprise Contract Lifecycle Management: During Q3 FY2017, Determine introduced a range of additional benefits that empower customers to deliver results now, and as they grow. These include the following improvements to the Determine Cloud Platform : improved supplier certification and compliance through triggered automation based on answers provided during registration and supplier monitoring, side-by-side comparison of contract requests and attachments for enhanced version control and user authorization, time tracking for services procurement that requires calendar management, PO matching, and automatic receipt/invoice generation. In addition, the Determine Cloud Platform mobile application is now available on Google Play and the Apple Store.
  • Business Analyst Recognition across the Determine Cloud Platform: In Q3 FY2017, Determine achieved a number of important recognitions from leading industry analyst organizations:
  • New Leadership: In October 2016, Determine appointed Steve Potts as Chief Revenue Officer. Steve brings over thirty years of sales management, sales performance management, and sales training experience in the enterprise software and SaaS sectors. He most recently served as Chief Sales and Marketing Officer at AXIOM Sales Force Development, a leading cloud-based sales training and productivity improvement supplier.
  • New Customer Expansions: During Q3 FY2017, Determine engaged numerous new customer accounts in the US and Europe across its Determine Cloud Platform Source-to-Pay and Enterprise Contract Lifecycle Management solutions. Determine added new customers to its portfolio including companies in key verticals such as energy, financial, healthcare products, consumer goods, manufacturing, and retail.
  • Thought Leadership: In Q3 FY2017, Determine continued to provide meaningful educational resources to inform our customers and prospects on the ever-changing Source-to-Pay and Enterprise Contract Lifecycle Management landscape:

Conference Call and Webcast: Thursday, February 9, 2017 at 5:00 PM (Eastern Time) Participant Conference Call Numbers: Toll-Free: 1-877- 407-0789 Toll/International: 1-201- 689-8562 Participant Webcast Link: http://public.viavid.com/index.php?id=122692 Replay Dial-in Information: Toll-Free: 1-844- 512-2921 Toll/International: 1-412- 317-6671 From: 02/09/17 @ 8:00 pm Eastern Time To: 02/16/17 @ 11:59 pm Eastern Time Replay Pin Number: 13653707 Related: http://investor.determine.com

Supporting Resources Determine blog Determine on LinkedIn Determine on Twitter Determine Resources

Non-GAAP Financial Measures

To supplement our financial results presented in accordance with Generally Accepted Accounting Principles (GAAP), this press release and the accompanying tables contain certain non-GAAP financial measures, including non-GAAP revenue, non-GAAP gross profit, non-GAAP net income and non-GAAP earnings per share, which we believe are helpful in understanding our past financial performance and future results. For reconciliations of these non-GAAP financial measures to the most directly comparable GAAP financial measures, please see the section of the accompanying tables titled, "GAAP to Non-GAAP Reconciliations". Our non-GAAP financial measures are not meant to be considered in isolation or as a substitute for comparable GAAP measures and should be read in conjunction with our consolidated financial statements prepared in accordance with GAAP.

The difference between GAAP and non-GAAP revenue is due to the impact of revaluing the deferred revenue balances acquired from primarily b-pack, Inc. as required by GAAP purchase accounting.

The difference between GAAP and non-GAAP gross profit is the difference in GAAP versus non-GAAP revenues as well as the elimination of the amortization of acquisition related intangibles, stock based compensation and severance expense from the costs of revenue. Non-GAAP net loss excludes the non-GAAP gross profit items as well as acquisition related costs.

Our management regularly uses our supplemental non-GAAP financial measures internally to understand and manage our business and forecast future periods; as such, we believe it is useful for investors to understand the effects of these items on our total operations. Further, please note that our non-GAAP revenue is intended to reflect the full amount of revenues that would have been otherwise recorded by the acquired entities of Iasta.com, Inc. and b-pack, Inc. while our non-GAAP gross profit also excludes the amortization of intangibles that occurred due to the acquisition of the entities of Iasta.com, Inc. and b-pack, Inc.

Annualized Bookings are an operating measure not derived from the company's revenues or any other amounts presented in accordance with GAAP in the company's statement of income, balance sheet, statement of cash flows or other equivalent statements.

"Annualized Bookings" means the annualized recurring contracted revenue from a new customer or a cross-sell or upsell to an existing customer.

Forward-looking Statements

Certain statements in this release and elsewhere by Determine are forward-looking statements within the meaning of the federal securities laws and the Private Securities Litigation Reform Act of 1995. Such statements may include, without limitation, statements regarding business outlook, assessment of market conditions, anticipated financial and operating results, strategies, product and channel development, future plans, contingencies and contemplated transactions of the company. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and other factors which may cause or contribute to actual results of company operations, or the performance or achievements of the company or industry results, to differ materially from those expressed, or implied by the forward-looking statements. In addition to any such risks, uncertainties and other factors discussed elsewhere herein, risks, uncertainties and other factors that could cause or contribute to actual results differing materially from those expressed or implied for the forward-looking statements include, but are not limited to fluctuations in demand for Determine's products and services, risks of losing key personnel or customers, protection of the company's intellectual property and government policies and regulations, including, but not limited to those affecting the company's industry. Determine undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise. Additional risk factors concerning the company can be found in the company's most recent Form 10-K as filed by the company with the Securities and Exchange Commission.

About Determine, Inc.

Determine, Inc. ( NASDAQ : DTRM ) is a leading global provider of SaaS Source-to-Pay and Enterprise Contract Lifecycle Management (ECLM) solutions. Our visionary technologies allow our customers to effectively manage the full scope of Source-to-Pay and Enterprise Contract Lifecycle Management using our Determine Cloud Platform. Our Source to Pay SaaS suite includes strategic sourcing, supplier management, contract management and procure-to-pay applications.

The Determine Cloud Platform gives procurement, finance and legal professionals the ability to deliver profound insights through analysis of their supplier relationships and contractual requirements. Our customers leverage the Determine Cloud Platform to discover previously unseen supplier and spend data; make more informed and smarter business decisions; drive new revenue; control costs; improve workflow efficiencies; and mitigate risk.

Our customers benefit from the Determine Cloud Platform's robust suite of integrated applications. Whether they start with a full-suite implementation or choose to implement just one application and build over time, each application allows for the automatic sharing of data in place on the Determine Cloud Platform.

For more information, please visit: www.determine.com .

   
   
   
Determine, Inc.  
Condensed Consolidated Statements of Operations  
(In thousands, except per share amounts)  
(Unaudited)  
               
      Three Months Ended     Nine Months Ended  
      December 31     December 31  
      2016     2015     2016     2015  
                                   
Revenues:                              
  Recurring revenues $ 5,054       5,354     $ 15,267     $ 15,862  
  Non-recurring revenues   1,798       1,746       4,661       4,218  
  Total revenues   6,852       7,100       19,928       20,080  
                                   
Cost of revenues:                              
  Cost of recurring revenues   1,777       1,816       5,085       5,003  
  Cost of non-recurring revenues   1,734       1,602       4,978       4,583  
  Total cost of revenues   3,511       3,418       10,063       9,586  
                                   
Gross profit:                              
  Recurring gross profit   3,277       3,538       10,182       10,859  
  Non-recurring profit (loss)   64       144       (317 )     (365 )
  Total gross profit   3,341       3,682       9,865       10,494  
                                   
Operating expenses:                              
  Research and development   1,049       1,230       3,052       2,851  
  Sales and marketing   2,273       3,310       7,843       10,313  
  General and administrative   1,761       2,072       5,432       6,211  
  Impairment of software devlopment costs   -       -       947          
    Total operating expenses   5,083       6,612       16,327       19,375  
                                   
Loss from operations   (1,742 )     (2,930 )     (6,462 )     (8,881 )
                                   
Interest and other (expense), net   (462 )     (149 )     (1,388 )     (549 )
Net loss before income tax   (2,204 )     (3,079 )     (7,850 )     (9,430 )
                                   
Benefit from income taxes   35       233       143       213  
Net loss   (2,169 )     (2,846 )     (7,707 )     (9,217 )
                                   
Net income (loss) attributed to non-controlling interest   (24 )     1       (36 )     5  
Net loss attributable to Determine, Inc.   (2,193 )     (2,845 )     (7,743 )     (9,212 )
                                   
Redeemable preferred stock accretion   -       -       -       1,000  
Net loss attributable to common stockholders $ (2,193 )   $ (2,845 )   $ (7,743 )   $ (10,212 )
                                   
Basic and diluted net loss per share $ (0.18 )   $ (0.25 )   $ (0.67 )   $ (0.90 )
                                   
                           
                           
Determine, Inc.  
GAAP to Non-GAAP Reconciliations  
(In thousands)  
(Unaudited)  
                                   
Reconciliation of total revenue:                              
  U.S. GAAP as reported $ 6,852     $ 7,100     $ 19,928     $ 20,080  
  Adjustments:                              
  Deferred revenue adjustment   -       87       8       228  
Non-GAAP revenue $ 6,852     $ 7,187     $ 19,936     $ 20,308  
                                   
Reconciliation of gross profit:                              
  U.S. GAAP as reported $ 3,341     $ 3,682     $ 9,865     $ 10,494  
  Adjustments:                              
  Deferred revenue adjustment   -       87       8       228  
  Amortizaton of acquision   250       250       758       630  
  Stock based compensation   111       92       240       218  
  Severance   24       24       25       107  
Non-GAAP gross profit $ 3,726     $ 4,135     $ 10,896     $ 11,677  
                                   
Reconciliation to non-GAAP net loss:                              
Net loss $ (2,193 )   $ (2,845 )   $ (7,743 )   $ (9,212 )
Stock-based compensation expense   630       658       1,867       1,871  
Deferred revenue adjustment   -       87       8       228  
Acquisition related costs   -       138       -       912  
Amortization on intangibles   526       542       1,594       1,373  
Benefit for income taxes   -       (213 )     (13 )     (213 )
Severance costs   27       130       34       456  
Non-GAAP net loss $ (1,010 )   $ (1,503 )   $ (4,253 )   $ (4,585 )
                                   
Non-GAAP basic and diluted net loss per share $ (0.08 )   $ (0.13 )   $ (0.37 )   $ (0.45 )
                                   
Weighted average shares outstanding for basic                              
and diluted net loss per share   11,944       11,244       11,466       10,212  
                                   
                         
                         
Determine, Inc.  
Condensed Consolidated Statements of Comprehensive Loss  
(In thousands)  
(Unaudited)  
   
    Three Months Ended     Nine Months Ended  
    December 31     December 31  
    2016     2015     2016     2015  
                                 
Net loss   $ (2,169 )   $ (2,846 )   $ (7,707 )   $ (9,217 )
Other comprehensive income (loss) net:                                
  Foreign currency translation adjustments     44       (11 )     31       (68 )
  Non-controlling interest     (24 )     1       (36 )     5  
Other comprehensive income (loss)     20       (10 )     (5 )     (63 )
Comprehensive loss   $ (2,149 )   $ (2,856 )   $ (7,712 )   $ (9,280 )
                                 
                                 
         
Determine, Inc.
Condensed Consolidated Balance Sheets
(In thousands)
         
         
         
    December 31,   March 31,
    2016   2016
    (Unaudited)   (Audited)
ASSETS            
Current assets            
  Cash and cash equivalents   $ 9,387   $ 9,418
  Accounts receivable, net     6,759     7,031
  Restricted cash     34     34
  Prepaid expenses and other current assets     1,408     1,551
    Total current assets     17,588     18,034
             
Property and equipment, net     94     136
Capitalized software, net     2,131     1,699
Goodwill     14,346     14,490
Other intangibles, net     6,346     8,011
Other assets     1,492     1,843
    Total assets   $ 41,997   $ 44,213
             
             
LIABILITIES AND EQUITY            
Current liabilities            
  Credit facility   $ 10,861   $ 9,000
  Accounts payable     2,435     1,973
  Accrued payroll and related liabilities     1,802     1,655
  Other accrued liabilities     2,020     2,396
  Deferred revenue     10,028     10,299
  Income tax payable     78     14
  COFACE loan     222     407
  Accrued restructuring     -     403
    Total current liabilities     27,446     26,147
  Long-term deferred revenue     5     67
  Convertible note, net of debt discount     7,374     5,420
  Other long-term liabilities     1,055     1,382
  Deferred tax liability non current     81     290
    Total liabilities     35,961     33,306
             
Total Determine, Inc. stockholders' equity controlling interest     5,887     10,794
Non-controlling interest     149     113
Total equity     6,036     10,907
    Total liabilities and equity   $ 41,997   $ 44,213
             
             
             
Determine, Inc.  
Condensed Consolidated Statements of Cash Flows  
(In thousands)  
(Unudited)  
             
             
    Nine Months Ended  
    December 31,     December 31,  
    2016     2015  
                 
Operating activities                
Net loss   $ (7,707 )   $ (9,217 )
Adjustments to reconcile net loss to net cash used in                
operating activities:                
  Depreciation and amortization     2,478       1,868  
  Loss on disposition of property and equipment     -       14  
  Stock-based compensation expense     1,867       1,870  
  Deferred tax liability     (209 )     93  
Changes in assets and liabilities:                
  Accounts receivable, net     272       149  
  Prepaid expenses and other current assets     143       300  
  Other assets     435       (380 )
  Accounts payable     462       113  
  Accrued payroll and related liabilities     147       278  
  Accrued restructuring costs     (403 )     -  
  Other accrued liabilities and other long-term liabilities     (356 )     (13 )
  Deferred revenue     (333 )     (281 )
Net cash used in operating activities     (3,204 )     (5,206 )
                 
Investing activities                
  Purchase of property and equipment     (39 )     (6 )
  Capitalized software     (1,267 )     (1,077 )
  Purchase of business, net of cash     -       (826 )
  Minority shareholder payment     -       (133 )
Net cash used in investing activities     (1,306 )     (2,042 )
                 
Financing activities                
  Proceeds from sale of common stock, preferred stock and warrants, net of issuance costs     -       310  
  Employee taxes paid in exchange for restricted stock awards forefeited     78       263  
  Issuance of common stock under employee stock plan     80       87  
  Credit facility borrowing     3,000       885  
  Credit facility payment     (1,139 )     (347 )
  Repayment of loan     (185 )     (25 )
  Conversion of preferred stock to common stock     -       (17 )
  Issuance of debt, net of costs     2,429       2,743  
Net cash provided by financing activities     4,263       3,899  
                 
  Effect of exchange rate changes on cash     216       11  
                 
Net decrease in cash and cash equivalents     (31 )     (3,338 )
Cash and cash equivalents at beginning of the period     9,418       13,178  
Cash and cash equivalents at end of the period   $ 9,387     $ 9,840  
                 
                         
                         
Determine, Inc.  
Billings Reconciliation  
(In thousands)  
(Unaudited)  
                         
                         
    Three Months Ended     Nine Months Ended  
    December 31,     December 31,     December 31,     December 31,  
    2016     2015     2016     2015  
                                 
Total revenues   $ 6,852     $ 7,100     $ 19,928     $ 20,080  
Deferred revenue:                                
End of period     10,033       9,019       10,033       9,019  
Beginning of period     9,340       8,319       10,366       8,432  
Change in deferred revenue     693       700       (333 )     587  
Total billings (total revenues plus the change in deferred revenue)   $ 7,545     $ 7,800     $ 19,595     $ 20,667  
                                 
                                 
                                 
Determine, Inc.  
Non-GAAP EBITDA Reconciliation  
(In thousands)  
(unaudited)  
                         
    Three Months Ended     Nine Months Ended  
    December 31     December 31  
    2016     2015     2016     2015  
Reconciliation to non-GAAP EBITDA net loss:                                
Non-GAAP net loss   $ (1,010 )   $ (1,503 )   $ (4,253 )   $ (4,585 )
Interest     461       131       1,299       372  
Depreciation     348       161       916       498  
Income Taxes and Minority Shareholder     (11 )     (233 )     (107 )     (217 )
Non-GAAP EBITDA net loss   $ (212 )   $ (1,444 )   $ (2,145 )   $ (3,932 )
                                 

 

Contact Media Relations Rose Lee Determine, Inc. +1.877.806.1932 +1.650.532.1590 pr@determine.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

TORRAS Stands Tall with iPhone 18 Pro Cases

Updated Category News Views 239

TORRAS Shines in Magnetic Stand Case Evaluation In the whirlwind of smartphone accessories, where the battle lines are drawn between protection and functionality, TORRAS has emerged victorious with its magnetic stand cases for the iPhone 18 Pro and its beefier brother, the iPhone 18 Pro Max. Expert Consumers—a trusted name in product evaluations—has given TORRAS the...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 138

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 375

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Master Sommeliers and Italian Producers Clash on Wine Lists

Updated Category News Views 166

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 92

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 159

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
Aluminum Design Fumble: Geometry Over Wall Thickness

Updated Category News Views 218

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

Continue Reading
Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

Updated Category News Views 170

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 184

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 81

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading

Top 5 Most Recently Viewed Articles

Skyline Builders Group Secures $23.9 Million Funding for Growth

Updated Category News Views 271

Skyline Builders Group Holding Limited's Latest Private Placement Skyline Builders Group Holding Limited (NASDAQ: SKBL), a prominent civil engineering services provider in Hong Kong, has made headlines recently with its announcement of a significant funding initiative. The company is moving forward with a private placement that aims to raise an impressive $23.9 million....

Continue Reading
Target Hospitality's Q1 Results Highlight Strategic Growth Path

Updated Category News Views 124

Target Hospitality Delivers Impressive First Quarter Results Target Hospitality Corp. (NASDAQ: TH), a leading provider of integrated modular accommodations and hospitality services, has showcased its resilience and strategic growth during the first quarter. The company announced substantial results for its operations that concluded on March 31, 2025, marked by a keen...

Continue Reading
Why Estero, FL Is the New Hotspot for Relocation

Updated Category News Views 6

Escaping the Cold: A Migration to Estero It seems Estero, FL is becoming the new darling for those tired of shoveling snow. Marty Pecoraro from MP Realty Group spills the beans on why this sunny spot is pulling in folks from all corners. The Draw of a Warmer Lifestyle Forget just chasing sunshine. The trend of moving to Estero isn't about lounging in the sun like a...

Continue Reading
Pega's Global Expansion of Developer Training for Future Pros

Updated Category News Views 53

Pegasystems Inc (NASDAQ: PEGA) kicked off a major expansion of its Pega University Program, trying to tackle the escalating demand for software developers. This initiative had already shown promise in India and aimed to spread across North America, Europe, and Asia Pacific. Back then, the industry was choking on a talent shortage that had firms scrambling; projections...

Continue Reading
Pony AI's Robotaxi Service Revolutionizes Urban Transportation

Updated Category News Views 262

Introduction to Pony AI's Innovative Robotaxi Services Pony AI Inc. (“Pony.ai” or the “Company”) (NASDAQ: PONY), renowned for its pioneering solutions in autonomous mobility, has marked a new chapter in urban transportation. The introduction of paid robotaxi services in the heart of Guangzhou is a groundbreaking move, connecting residents and travelers to major...

Continue Reading